Finding Cures
for Cancer

Cancer Therapeutics CRC (CTx) is in the business of finding cures for cancer.  The major focus for our drug discovery is early intervention in metastatic or recurrent cancer. We bring this focus not only to common adult cancers, but also to the somewhat neglected area of new cancer drugs for children. Read more…

Successful in Funding Application

Today (Friday 21 February 2014) Cancer Therapeutics CRC received the decision from the CRC Program that the application for six years extension funding was approved. Read media release...

Drug Discovery Pipeline

CTx translates innovative cancer biology research into lead and preclinical stage small molecule drug candidates. To date, we have out-licensed four novel compounds for further preclinical and clinical development, and have a strong pipeline of Hit Discovery, Lead, and Candidate Generation projects. Read more...

Partnering

Cancer Therapeutics CRC has a pipeline of innovative early stage small molecule oncology programs, backed up with data-rich packages, which are available for partnering or out-licensing. Read more...

 
© Cancer Therapeutics CRC 2014   Website by College Hill